The production of alkaloids in Annona cacans seedlings is affected by the application of GA4+7 + 6-Benzyladenine

The Annonaceae family presents alkaloids with ecological functions and pharmacological interest. This is the first study to evaluate if the application of plant growth regulators to seeds of this family alters the production of alkaloids over time from germination. This study was carried out in four sequential stages of Annona cacans Warm. development from the resumption of embryo during seed imbibition with the application of plant regulator GA₄₊₇ + 6-Benzyladenine. The concentration of total alkaloids was quantified using the oxoaporphine alkaloid liriodenine as reference standard. In addition, the liriodenine concentration was measured and the profile evaluated by ultra-high-performance liquid chromatography (UHPLC). Results have shown that alkaloids are present in all phases and in all tissues, at higher concentrations in roots (up to 100 times). The proportion of total alkaloids and liriodenine was modified in response to the application of plant regulators. Roots doubled the content of alkaloids and liriodenine. In cotyledonary leaves, the amount of total alkaloids decreased; however, liriodenine remained unchanged. Our results have shown that the use of plant growth regulators based on gibberellins and cytokinins modified the production of alkaloids in tissues in a specific way.     

狭叶花椒化学成分研究(Ⅱ)

从芸香科植物狄叶花椒(Zanthoxylum stenophyllum Hemls)根皮中分到5个化合物。通过IR,Uv,MS,¹HNMR,¹³CNMR,¹H-¹Hcosy,¹³CNMR-APT,¹³CNMR-DEPT,元素分析等手段,单体分别鉴定为β-谷甾醇(β-sitosterol),双狭叶花椒碱(bistenofine),鹅掌楸宁(liridenine),Decarine,Arnottianamide。其中双狭叶花椒碱是一种新生物碱。     

薄层扫描法测定毛两面针三种生物碱的含量

从广西大瑶山产毛两面针中提取到了鹅掌楸碱(Ⅰ)、白屈菜红碱(Ⅱ)、氯化两面针碱(Ⅲ)三种生物碱,用薄层扫描法(TLCS)同时测定其含量,并与玉林、百色两面针中的同种生物碱进行对比。研究表明,毛两面针和两面针均含Ⅱ、Ⅲ,在毛两面针还能检测到Ⅰ的存在,其含量为0.00957%。     

The vascular and cardioprotective effects of liriodenine in ischemia–reperfusion injury via NO-dependent pathway

Liriodenine is an aporphine derivative isolated from the plant Fissistigma glaucescens. Electrophysiological action, particularly the blockage of Na+ and K+ channels, contributes to the drug's well-known anti-arrhythmic action. However, liriodenine's cardioprotective efficacy and the relation of the channel blockages to the efficacy are poorly known, as is the drug's effect on coronary flow and endothelial function. The present study evaluated the protection conveyed by liriodenine to myocardium and coronary endothelial cells under conditions of ischemia-reperfusion and to assess the involvement of a nitric oxide (NO)-dependent mechanism. In the Langendorff model utilizing Sprague-Dawley rat hearts, the left main coronary artery was occluded for 30 min and reperfusion for 120 min. Liriodenine (1 microM) significantly promoted the recovery of coronary flow and decreased myocardial infarction compared with vehicle-treated hearts. The drug attenuated the reduction of endothelial reactivity and NO release. To simulate the condition that occurs in the ischemic stage, human umbilical vein endothelial cells (HUVEC) were cultured in serum free conditions. Liriodenine showed concentration-dependent effects on cell viability associated with anti-apoptosis under serum-deprivation. Liriodenine prevented eNOS reduction in serum-deprived HUVEC and ischemia-reperfusion hearts. The vascular and cardioprotective effects were reversed by N(G)-nitro-L-arginine methyl ester. Another Na+ and K+ channel blocker with similar activities as liriodenine (quinidine) failed to protect endothelial cells and myocytes. These results demonstrate that liriodenine reduces the extent of cardiovascular injuries under ischemia-reperfusion conditions mainly by preserving the eNOS and the NO production.